Contents
Patient brokering is paying or receiving money or another benefit for treatment referrals. Also called body brokering, it turns a person seeking care into a source of referral income. The payment can reach a recruiter, a marketer or a sober-home operator. It can buy an admission or keep someone attending the same program. If you work in admissions, marketing, billing or recovery housing, you may see the connection between the referral fee and the treatment revenue before anyone looking only at the clinical chart does.
Patients can lose control over where they receive care, while insurers and public programs pay for treatment shaped by the referral money. The revealing detail is often what makes the payment change. Does the broker receive more when the insurer pays more? Does the housing subsidy end when the patient leaves treatment? Does the laboratory pay a facility employee who controls where specimens go? Those questions connect the contract to the business it actually buys.
A referral payment can be cash, a share of insurance receipts, housing or transportation. The benefit can go directly to the patient or to someone who controls the patient’s route into care. The contract’s name tells only part of that story.
In the criminal case involving Healing Path Detox and Get Real Recovery, the operator paid nearly $2.9 million in kickbacks to patient brokers. The Justice Department’s account of the trial and conviction described fixed marketing arrangements that concealed a body broker’s compensation tied to the addiction center’s insurance receipts and billable days. The paperwork said fixed. The money followed the patients.
A rehab marketing contract can say fixed fee while the broker is paid per patient. The insurance value and days billed determine the referral fee. An admissions ledger identifies the patient and referral source. The insurer’s payment record shows the receipts. The broker’s invoice and payment ledger show whether the supposed fee moved with them.
The receiving side appears in a separate Orange County prosecution. In his guilty plea, a patient broker admitted receiving shares of private-insurance proceeds for referred patients, as described in the Justice Department’s case announcement. A patient broker paid a percentage of insurance reimbursement has a direct stake in the claims that follow the referral.
When sober home rent depends on attending one treatment center, the housing payment buys continuing attendance. Bournewood’s housing settlement makes that condition unusually clear. The company admitted paying sober homes only while patients enrolled in and attended its partial hospitalization program. Recovery housing payments stopped when partial hospitalization attendance stopped, even when the patient still needed housing.
The admitted arrangement ran from September 16, 2013 through May 31, 2022. Bournewood agreed to a minimum $5.5 million civil settlement, with additional payments dependent on future income.
The whistleblower’s complaint described housing and transportation as ways to maintain a stream of billable patients:
Defendants also provided transportation for the Patients directly and/or through RES, to transport the Patients to and from Defendants’ facilities to receive the Medical Services. The transportation was also a form of inducement and means to control the Patients, in addition to providing Free Housing, in order to create a billing pool of patients for the Medical Services to be billed to the Government Healthcare Programs.
United States ex rel. Perry v. Planners, whistleblower complaint, paragraph 20
That is the whistleblower’s allegation about the arrangement’s purpose. Bournewood’s own admission supplies the attendance condition. The invoice, attendance dates and instructions to end payment show how the arrangement worked.
The company paying the rent, the operator receiving it and the program billing for treatment each hold a different part of the same transaction.
Free long-distance rides figured in psychiatric hospital kickback allegations against Oglethorpe’s Ohio facilities. The government alleged that the facilities used the transportation to induce Medicare beneficiaries to obtain treatment. The March 2021 civil settlement also addressed allegations of unnecessary psychiatric admissions at Cambridge and Ridgeview.
Turning Point Care Center, a Universal Health Services facility in Georgia, agreed to a separate $5 million civil settlement over alleged free or discounted transportation for Medicare and Medicaid patients. The alleged inducement covered detoxification, rehabilitation and intensive outpatient attendance.
Fee forgiveness can buy attendance too. The Turning Point whistleblower’s complaint alleged routine waivers of patients’ copayments and deductibles to induce services billed to Medicare.
Patient brokering works by paying for access to patients and the treatment revenue that follows them. The business that recruits a person, the residence that houses them, the clinician who orders services and the company submitting claims can be different organizations. A useful account follows the patient and the payments across those boundaries.
The ordinary admissions business already joins several functions. AAC Holdings’ 2018 company filing described owned addiction websites and a centralized admissions center handling benefits verification, insurer communications, screening, precertification, facility selection and logistics. That disclosure explains how much can happen between the first inquiry and arrival at a facility.
In a brokering case, those same operational records can show who selected the destination and whose compensation depended on that choice. An employee handling benefits verification may see the insurance value. A residence operator may see the attendance requirement. Accounts payable may see the money leaving the treatment business. We connect those views to the claims that financed the arrangement.
A paid recruiter disguised as a case manager can make purchased referrals look like treatment support. In the Biscayne Milieu criminal trial, the evidence described sham case-manager contracts alongside ineligible patients, falsified records and services that were not provided or could not be reimbursed. The Justice Department’s account of that trial supplies the connection between the recruiter payment and the clinical paperwork.
American Therapeutic Corporation shows the same connection from another direction. The Justice Department’s account of its criminal case described payments to assisted-living operators, halfway houses and brokers to supply beneficiaries, and altered diagnoses, medication information and therapist notes to make patients appear eligible for Medicare partial hospitalization. The criminal-case opinion also described billing summaries and patient logs used to calculate cash payments.
The referral records and the clinical records served the same scheme. One brought patients in. The other made those patients appear to qualify for the service being billed. For an insider, a contract describing case management belongs beside evidence of what the person actually did and how the payment was calculated.
Buying the referral can be only one transaction in a longer arrangement. Insurance enrollment creates the coverage, treatment generates claims, and laboratory referrals can generate another payment back to the treatment operation.
The criminal indictment involving Sovereign Health Group, described in the Justice Department’s announcement, alleged that its founder and a co-defendant used a purported foundation to obtain identities, invented qualifying life events, manipulated income and paid premiums to enroll people in subsidized commercial coverage. It also alleged purchased patient referrals. Patients generally did not know about or authorize the insurance applications made in their names.
Those allegations put enrollment and premium records beside the referral ledger. The person recruiting the patient and the person creating the insurance application controlled different steps toward a reimbursable admission. The clinical chart would not show the whole transaction.
The Justice Department’s account of the Reflections Treatment Center and Journey to Recovery criminal case described the owner supplying drugs when patients’ benefits were about to expire, obtaining positive tests and representing that patients had relapsed to extend coverage. Sober-home payments depended on insured attendance, and laboratory kickbacks influenced the type and frequency of testing. Some results were never reviewed.
The treatment business supplied drugs, then used the resulting relapse to keep billing. The patient’s continued drug use served the business that was paid to treat it.
LabTox’s whistleblower complaint alleged that collector payments displaced a facility’s payroll costs and rewarded specimen referrals. The benefit could reach the treatment operation through an employee’s wages. The allegation was that LabTox paid excessive collector compensation even when it knew the claimed collection time exceeded the work performed.
The alleged benefit was a staffing expense the facility no longer had to carry. A check from the laboratory could go to the employee while still helping the facility that chose the laboratory. That is why the recipient’s name on the payment is only the start: the facility’s displaced payroll expense shows who else benefited.
The complaint also described a striking disconnect between the physician’s name on the order and access to the result:
However, the password to access the information system would only be given by Labtox to the Facility, and not to the physician who was supposedly ordering the test.
United States ex rel. Secamiglio v. LabTox, LLC, whistleblower complaint, paragraph 80
The same complaint alleged that collectors selected tests under a physician’s standing order and marked the signature as on file. These allegations connect the referral payment to the test order and to who could review the result. The collector’s payroll, the selected tests and the physician’s access each answer a different part of the billing question.
LabTox later agreed to civil judgments totaling $10,458,933. The government’s account concerned nonmedical testing billed as medically necessary, including tests from residential recovery programs and shelters. That is a concrete reason to follow the transaction beyond admission: the laboratory claim can reveal a separate payment arrangement around the same patient.
The referral payment shows what someone paid to obtain business. The treatment claim shows what the provider asked an insurer or government program to cover. Connecting them requires the patient, the service and the dates, together with the payment formula that made the referral valuable.
For someone inside the operation, that distinction gives ordinary records their significance. A commission ledger can connect a recruiter to the insurer’s receipts. A housing invoice can connect rent to attendance at a particular program. Collector compensation can connect a facility’s payroll to its choice of laboratory. We examine those records with the relevant admissions, treatment dates, orders and claims to establish what the payment purchased.
The person receiving care can be caught between those businesses. The government’s account of the Reflections owner’s guilty plea described reduced rent, drugs, threats and confiscated possessions used to control patients. The payment trail explains the operator’s power over where the patient stayed and whether the treatment revenue continued.
The payer, treatment setting, recipient and payment formula determine which patient-brokering rules matter. The federal Anti-Kickback Statute, the Eliminating Kickbacks in Recovery Act, commonly called EKRA, and state laws reach different arrangements.
For government-funded care, the Anti-Kickback Statute connects prohibited referral payments to the claims resulting from them. Those claims can support a False Claims Act case. That connection puts the recruitment agreement and the Medicare or Medicaid bill in the same inquiry.
EKRA reaches qualifying public and private health care benefit programs. Its covered settings include recovery homes, laboratories and nonhospital substance-use treatment facilities.
State law adds another layer, including Florida’s patient-brokering law. Whether a particular private-insurance arrangement can support a whistleblower reward is a question we work through with you and whistleblower lawyers who understand treatment referrals.
The central question is whether money or another benefit bought the referral or continuing attendance. We examine who paid, who received the benefit, what changed the amount, which program received the patient and what care was billed on the relevant dates.
An insider may hold the missing connection: the commission ledger that tracks insurance receipts, the instructions to stop paying rent after discharge, or the staffing arrangement that routes specimens to a paying laboratory. The cases above show why the payment terms and the work actually performed belong together. Our whistleblower experts connect that inside knowledge to the business’s payment decisions and the claims they produced.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know how a treatment business pays for patients, speak to our whistleblower experts about what the referral bought. We connect the referral money to admissions, housing conditions and insurance claims to build your strongest whistleblower case. We bring in healthcare fraud whistleblower lawyers who know addiction-treatment referrals, and we stay beside you throughout the process.